levonorgestrel and Disease

Topics: Amenorrhea; Biology; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Contraceptives, Oral; Disease; Endocrine System; Family Planning Services; Hemorrhage; Hormones; Injections; Intrauterine Devices; Lactation; Levonorgestrel; Menstrual Cycle; Menstruation; Menstruation Disturbances; Norethindrone; Physiology; Pregnancy; Progesterone; Progestins; Reproduction; Signs and Symptoms

Topics: Age Factors; Amenorrhea; Biology; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Disease; Endocrine System; Family Planning Services; Follicle Stimulating Hormone; Gonadotropins; Gonadotropins, Pituitary; Hormones; Levonorgestrel; Luteinizing Hormone; Menstruation; Menstruation Disturbances; Parity; Physiology; Pituitary Gland; Pituitary Hormones; Prolactin; Reproduction; Reproductive Control Agents

Topics: Asia; Asia, Southeastern; Biology; Contraception; Contraception Behavior; Contraceptive Agents; Contraceptive Agents, Female; Contraceptives, Oral; Data Collection; Developing Countries; Disease; Endocrine System; Family Planning Services; Hemorrhage; Hormones; Levonorgestrel; Malaysia; Menstruation Disturbances; Metrorrhagia; Norethindrone; Patient Acceptance of Health Care; Physiology; Research; Sampling Studies; Signs and Symptoms; Statistics as Topic

Topics: Age Factors; Biology; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Contraceptives, Postcoital; Disease; Economics; Endocrine System; Family Planning Services; Hormones; Levonorgestrel; Menstruation Disturbances; Physiology; Population; Population Characteristics; Reproductive Control Agents; Research; Technology

Topics: Biology; Birth Rate; Breast; Contraception; Contraception Behavior; Contraceptive Agents; Contraceptive Agents, Female; Contraceptives, Oral; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Contraceptives, Postcoital; Demography; Developed Countries; Digestive System; Disease; Embryo Implantation; Embryonic Development; Endocrine System; Ethics; Ethinyl Estradiol; Europe; Family Planning Services; Fertility; Hormones; Infections; Intrauterine Devices; Intrauterine Devices, Copper; Levonorgestrel; Menstruation Disturbances; Nausea; Netherlands; Parity; Pelvic Inflammatory Disease; Physiology; Population; Population Dynamics; Pregnancy; Pregnancy Complications; Pregnancy Trimester, First; Pregnancy, Ectopic; Reproduction; Signs and Symptoms; Vomiting

Topics: Age Factors; Behavior; Biology; Blood; Blood Coagulation; Carbohydrates; Cardiovascular System; Cause of Death; Cholesterol; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Contraceptives, Oral, Hormonal; Demography; Disease; Endocrine System; Ethinyl Estradiol; Family Planning Services; Glucose; Hormones; Levonorgestrel; Lipids; Metabolism; Mortality; Norethindrone; Organic Chemicals; Physiology; Population; Population Characteristics; Reproductive Control Agents; Smoking; Social Behavior; Vascular Diseases

Topics: Biology; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Contraceptives, Oral, Hormonal; Contraceptives, Postcoital; Diethylstilbestrol; Disease; Endocrine System; Estrogens; Ethinyl Estradiol; Family Planning Services; Hormones; Intrauterine Devices; Levonorgestrel; Norgestrel; Physiology; Pregnancy Complications; Pregnancy, Ectopic; Reproductive Control Agents

Topics: Biology; Blood; Blood Coagulation; Blood Pressure; Carbohydrates; Cholesterol; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Contraceptives, Oral; Contraceptives, Oral, Combined; Disease; Endometrium; Estradiol; Estrogens; Family Planning Services; Genitalia; Genitalia, Female; Glucose; Hormones; Levonorgestrel; Lipids; Menstruation Disturbances; Metabolism; Norethindrone; Physiology; Reproductive Control Agents; Urogenital System; Uterus

Topics: Biology; Carbohydrates; Chemical Phenomena; Chemistry; Cholesterol; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Contraceptives, Oral; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Cyproterone Acetate; Disease; Endocrine System; Ethinyl Estradiol; Ethynodiol Diacetate; Family Planning Services; Glucose; Hormone Antagonists; Hormones; Levonorgestrel; Lipids; Lynestrenol; Metabolism; Norethindrone; Norethynodrel; Norgestrel; Organic Chemicals; Physiology; Reproductive Control Agents

Topics: Biology; Birth Rate; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Demography; Developed Countries; Diagnosis; Disease; Economics; Endocrine System; Europe; Family Planning Services; Fertility; Finland; Genitalia, Female; Hormones; Intrauterine Devices; Levonorgestrel; Menstruation Disturbances; Physiology; Population; Population Dynamics; Pregnancy Rate; Reproductive Control Agents; Research; Research Design; Scandinavian and Nordic Countries; Technology; Urogenital System

Topics: Asia; Asia, Eastern; Consumer Product Safety; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Contraceptives, Oral; Contraceptives, Oral, Combined; Developed Countries; Disease; Evaluation Studies as Topic; Family Planning Services; Japan; Legislation as Topic; Levonorgestrel; Licensure; Risk Assessment; Signs and Symptoms

Topics: Asia; Asia, Southeastern; Biology; Body Weight; Contraception; Contraception Behavior; Contraceptive Agents; Contraceptive Agents, Female; Developing Countries; Disease; Family Planning Services; Follow-Up Studies; Levonorgestrel; Menstruation Disturbances; Patient Acceptance of Health Care; Physiology; Research; Singapore

Topics: Americas; Biology; Blood; Blood Pressure; Body Weight; Clinical Laboratory Techniques; Clinical Trials as Topic; Contraception; Contraception Behavior; Contraceptive Agents; Contraceptive Agents, Female; Contraceptives, Oral; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Developing Countries; Diagnosis; Disease; Ethinyl Estradiol; Evaluation Studies as Topic; Family Planning Services; Hemorrhage; Latin America; Levonorgestrel; Lipids; Menstrual Cycle; Menstruation; Metrorrhagia; Mexico; Norethindrone; North America; Patient Acceptance of Health Care; Physiology; Reproduction; Research; Signs and Symptoms

Topics: Americas; Congresses as Topic; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Developed Countries; Disease; Family Planning Services; Infections; Intrauterine Devices; Intrauterine Devices, Copper; Levonorgestrel; North America; Pelvic Inflammatory Disease; United States

Topics: Americas; Behavior; Community Health Workers; Contraception; Contraception Behavior; Contraceptive Agents; Contraceptive Agents, Female; Cost-Benefit Analysis; Decision Making; Developed Countries; Disease; Evaluation Studies as Topic; Family Planning Services; Health Planning; Infections; Intrauterine Devices; Intrauterine Devices, Copper; Intrauterine Devices, Medicated; Levonorgestrel; North America; Patient Acceptance of Health Care; Pelvic Inflammatory Disease; Postnatal Care; United States

Topics: Ambulatory Care Facilities; Biology; Cervix Mucus; Cervix Uteri; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Counseling; Disease; Family Planning Services; Genitalia; Genitalia, Female; Health Planning; Hemorrhage; Infections; Intrauterine Devices; Intrauterine Devices, Medicated; Levonorgestrel; Menstruation; Organization and Administration; Physiology; Reproduction; Sexually Transmitted Diseases; Signs and Symptoms; Urogenital System; Uterus

Topics: Ambulatory Care Facilities; Americas; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Contraceptives, Oral; Contraceptives, Oral, Combined; Counseling; Delivery of Health Care; Developed Countries; Disease; Family Planning Services; Health; Health Personnel; Health Planning; Levonorgestrel; Medroxyprogesterone Acetate; Menstruation Disturbances; North America; Therapeutics; United States

Topics: Africa; Africa, Northern; Biology; Contraception; Contraception Behavior; Contraceptive Agents; Contraceptive Agents, Female; Developing Countries; Diabetes Mellitus; Disease; Family Planning Services; Heart Diseases; Hypertension; Lactation; Levonorgestrel; Menstruation Disturbances; Middle East; Physiology; Pregnancy; Prospective Studies; Research; Risk Factors; Tunisia; Vascular Diseases

Topics: Asia; Asia, Eastern; China; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Developing Countries; Disease; Family Planning Services; Levonorgestrel; Menstruation Disturbances; Prevalence; Prospective Studies; Research; Research Design

Topics: Behavior; Central Nervous System; Chlormadinone Acetate; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Contraceptives, Oral; Digestive System; Disease; Family Planning Services; Hemorrhage; Levonorgestrel; Libido; Megestrol Acetate; Metrorrhagia; Nausea; Research; Sexual Behavior; Signs and Symptoms

Topics: Anovulation; Biology; Contraception; Contraception Behavior; Contraceptive Agents; Contraceptive Agents, Female; Contraceptives, Oral; Developed Countries; Diagnosis; Disease; Endocrine System; Endoscopy; England; Ethynodiol Diacetate; Europe; Family Planning Services; Genitalia; Genitalia, Female; Hormones; Levonorgestrel; Norethindrone; Ovarian Cysts; Ovary; Physical Examination; Physiology; Progesterone Congeners; Sexual Behavior; Ultrasonics; United Kingdom; Urogenital System

Topics: Age Factors; Behavior; Biology; Breast Feeding; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Contraceptives, Oral; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Contraceptives, Postcoital; Demography; Disease; Embolism; Endocrine System; Ethinyl Estradiol; Family Planning Services; Health; Heart Diseases; Hormones; Hypertension; Infant Nutritional Physiological Phenomena; Levonorgestrel; Liver Diseases; Mestranol; Morbidity; Mortality; Norethindrone; Nutritional Physiological Phenomena; Physiology; Population; Population Characteristics; Population Dynamics; Progesterone; Progestins; Smoking; Thromboembolism; Vascular Diseases

Topics: Asia; Asia, Southeastern; Biology; Blood; Blood Coagulation; Case-Control Studies; Clinical Laboratory Techniques; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Contraceptives, Oral; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Cross-Sectional Studies; Desogestrel; Developing Countries; Diagnosis; Disease; Embolism; Ethinyl Estradiol; Family Planning Services; Hematocrit; Hematologic Tests; Levonorgestrel; Malaysia; Methods; Physiology; Research; Research Design; Thromboembolism; Thrombosis; Vascular Diseases

Topics: Americas; Biology; Breast Neoplasms; Canada; Contraception; Contraception Behavior; Contraceptive Agents; Contraceptive Agents, Female; Developed Countries; Disease; Family Planning Services; Injections; Levonorgestrel; Medroxyprogesterone Acetate; Menstruation Disturbances; Metabolism; Neoplasms; North America; Patient Acceptance of Health Care; Physiology; Research

Topics: Contraception; Contraceptive Agents; Contraceptive Agents, Female; Developed Countries; Disease; Europe; Family Planning Services; Intrauterine Devices; Intrauterine Devices, Medicated; Levonorgestrel; Menstruation Disturbances; Scandinavian and Nordic Countries; United Kingdom

Topics: Biology; Communication; Consumer Product Safety; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Contraceptives, Oral; Delivery of Health Care; Demography; Desogestrel; Developed Countries; Disease; Embolism; Europe; Evaluation Studies as Topic; Family Planning Services; Geography; Health; Health Personnel; Knowledge; Levonorgestrel; Norethindrone; Population; Public Health; Residence Characteristics; Risk Assessment; Risk Factors; Safety; Thromboembolism; Thrombosis; United Kingdom; Vascular Diseases

Topics: Blood Coagulation; Breast; Chile; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Contraceptives, Oral; Contraceptives, Postcoital; Disease; Evaluation Studies as Topic; Family Planning Services; Levonorgestrel; Liver; Menstruation Disturbances; Peru; Pregnancy, Unwanted; Research

Topics: Age Factors; Amenorrhea; Americas; Anthropometry; Behavior; Biology; Body Weight; Colombia; Contraception; Contraception Behavior; Contraceptive Agents; Contraceptive Agents, Female; Demography; Developed Countries; Developing Countries; Diagnosis; Disease; Dysmenorrhea; Educational Status; Endocrine System; Evaluation Studies as Topic; Family Planning Services; Fertility; Headache; Hemorrhage; Hormones; Incidence; Latin America; Levonorgestrel; Menstrual Cycle; Menstruation; Menstruation Disturbances; Neurologic Manifestations; Parity; Patient Acceptance of Health Care; Physiology; Population; Population Characteristics; Population Dynamics; Reproduction; Reproductive Control Agents; Research; Research Design; Sexual Behavior; Signs and Symptoms; South America; Statistics as Topic

Topics: Americas; Arterial Occlusive Diseases; Arteriosclerosis; Biology; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Contraceptives, Oral; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Developed Countries; Disease; Ethinyl Estradiol; Family Planning Services; Levonorgestrel; Lipids; Norethindrone; Norgestrel; North America; Physiology; United States; Vascular Diseases

Topics: Asia; Asia, Southeastern; Biology; Blood; Blood Coagulation; Clinical Laboratory Techniques; Clinical Trials as Topic; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Contraceptives, Oral; Contraceptives, Oral, Combined; Developing Countries; Diagnosis; Disease; Embolism; Family Planning Services; Fibrinolysis; Hematologic Tests; Levonorgestrel; Malaysia; Physiology; Research; Thromboembolism; Thrombosis; Vascular Diseases

Topics: Aftercare; Asia; Asia, Southeastern; Birth Rate; Clinical Trials as Topic; Contraception; Contraception Behavior; Contraceptive Agents; Contraceptive Agents, Female; Demography; Developing Countries; Disease; Family Planning Services; Fertility; Hemorrhage; Intrauterine Devices; Intrauterine Devices, Copper; Intrauterine Devices, Medicated; Levonorgestrel; Pain; Population; Population Dynamics; Postpartum Period; Pregnancy Rate; Prospective Studies; Reproduction; Research; Signs and Symptoms; Singapore; Therapeutics; Time Factors